Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005586
Disease: Bipolar Disorder
Bipolar Disorder
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0005587
Disease: Depression, Bipolar
Depression, Bipolar
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0024713
Disease: Manic Disorder
Manic Disorder
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0338831
Disease: Manic
Manic
0.300 Biomarker disease CTD_human Genome-wide association study identifies 30 loci associated with bipolar disorder. 31043756 2019
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE The results showed that PLEKHO1 knockdown significantly inhibited cell viability and facilitated apoptosis in vitro and impaired tumour formation in vivo. 31180521 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.040 Biomarker disease BEFREE Importantly, deregulation of CKIP-1 results in osteoporosis, tumor, and atherosclerosis. 31082489 2019
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.020 AlteredExpression disease BEFREE PLEKHO1 was highly expressed in osteoblasts from RA patients and CIA mice. 30824383 2019
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 Biomarker phenotype BEFREE CKIP-1 also plays an important role as a critical regulator in tumorigenesis. 31355268 2019
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.020 Biomarker phenotype BEFREE CKIP-1 is involved in biological processes consisting of bone formation, tumorigenesis and immune regulation. 31082489 2019
CUI: C0003850
Disease: Arteriosclerosis
Arteriosclerosis
0.010 Biomarker disease BEFREE Moreover, Ckip-1-deficient mice undergo accelerated atherosclerosis, and bone marrow transplantation reveals that Ckip-1 deficiency in hematopoietic cells is sufficient to increase atherosclerotic plaque formation. 30683852 2019
CUI: C0003864
Disease: Arthritis
Arthritis
0.010 GeneticVariation disease BEFREE Osteoblastic Plekho1 deletion ameliorated joint inflammation, whereas overexpressing Plekho1 only within osteoblasts exacerbated local inflammation in CIA mice and STA mice. 30824383 2019
CUI: C0004153
Disease: Atherosclerosis
Atherosclerosis
0.010 Biomarker disease BEFREE Moreover, Ckip-1-deficient mice undergo accelerated atherosclerosis, and bone marrow transplantation reveals that Ckip-1 deficiency in hematopoietic cells is sufficient to increase atherosclerotic plaque formation. 30683852 2019
CUI: C0011334
Disease: Dental caries
Dental caries
0.010 AlteredExpression disease BEFREE Therefore, inhibiting the expression of CKIP-1 may be of great significance to the development of dental caries. 29852799 2019
CUI: C0017638
Disease: Glioma
Glioma
0.010 Biomarker disease BEFREE Overall, our results provided new insights into the clinical significance and molecular mechanism of CKIP-1 in glioma, which indicated CKIP1 might function as a therapeutic target for clinical treatment of glioma. 31355268 2019
CUI: C0027051
Disease: Myocardial Infarction
Myocardial Infarction
0.010 Biomarker disease BEFREE Overall, our findings demonstrate that CKIP-1 alleviates hypoxia-induced cardiomyocyte injury through the up-regulation of Nrf2 antioxidant signaling via the down-regulation of Keap1, suggesting a potential role for CKIP-1 in myocardial infarction. 31201843 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.040 Biomarker disease BEFREE The role of CKIP-1 in osteoporosis development and treatment.<i>Bone Joint Res</i> 2018;7:173-178. 29682283 2018
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis
0.020 Biomarker disease BEFREE In this article, two examples of rheumatoid arthritis are discussed, including a new biomarker candidate casein kinase 2 interacting protein 1 (CKIP-1) and a micro RNA 214. 30341484 2018
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.020 AlteredExpression disease BEFREE Our previous study indicated that Casein kinase 2 interacting protein-1 (CKIP-1) could promote the activation of the nuclear factor E2-related factor 2 (Nrf2)/ antioxidant response element (ARE) pathway, playing a significant role in inhibiting the fibrosis of diabetic nephropathy (DN). 29248720 2018
CUI: C0151650
Disease: Renal fibrosis
Renal fibrosis
0.020 AlteredExpression disease BEFREE Here, we investigated whether CKIP-1 affects the polyubiquitination of Nrf2 and its cytosolic inhibitor kelch like ECH-associated protein 1 (Keap1) via mediating Smad ubiquitylation regulatory factor-1 (Smurf1) to promote the activation of the Nrf2/ARE signaling and resist high glucose (HG)-induced renal fibrosis in glomerular mesangial cells (GMCs) and diabetic mice kidneys. 29248720 2018
CUI: C0001486
Disease: Adenovirus Infections
Adenovirus Infections
0.010 AlteredExpression group BEFREE Treatment of CKIP-1 adenovirus infection reduced the Smurf1 levels, promoted the activation of the Nrf2/ARE pathway as well as suppressed the production of reactive oxygen species (ROS), and then improved the failure of renal function of diabetic mice. 29248720 2018
CUI: C0029453
Disease: Osteopenia
Osteopenia
0.010 Biomarker disease BEFREE The aim of this study was to investigate the effect of constrained dynamic loading (Loading) in combination with CKIP‑1 gene knockout (KO) on unloading‑induced bone loss in tail‑suspension mice. 29956799 2018
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.040 Biomarker group BEFREE Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma. 27840970 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.040 Biomarker disease BEFREE Targeting osteoblastic CKIP-1 would be a novel bone anabolic strategy for GIO patients. 28128304 2017
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.040 Biomarker disease BEFREE Taken together, it suggests that the increased PLEKHO1 could suppress Smad-dependent BMP signaling to inhibit bone formation during aging, indicating the translational potential of targeting PLEKHO1 in osteoblast as a novel bone anabolic strategy for reversing established osteoporosis during aging. 28083909 2017
CUI: C0011881
Disease: Diabetic Nephropathy
Diabetic Nephropathy
0.020 Biomarker disease BEFREE Whereas, whether PD could resist DN through regulating CKIP-1 and consequently promoting the activation of Nrf2-ARE pathway needs further investigation. 28286065 2017